Brain metastasis screening in high-risk breast cancer
Part of Brain & nervous system, Cancer clinical trials.
This study looks at whether routine brain scans can help manage breast cancer that has spread to other parts of the body. It aims to find brain metastases early in people with certain types of high-risk breast cancer, even before symptoms appear.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that has spread to organs, lymph nodes, or bones (metastatic).
- You have one of these types: HER2-positive, triple-negative, or ER-positive after at least two prior treatments including a CDK4/6 inhibitor and with multiple bone or organ metastases.
- Your metastatic breast cancer was diagnosed within the last 3 months.
- You have no symptoms of brain metastasis and are willing to have a brain MRI.
- You are eligible for Medicare.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses regular MRI scans to screen for brain metastases in people with certain advanced cancers (HER2-positive or triple-negative breast cancer, non-small cell lung cancer, or melanoma). The goal is to detect brain spread early, which may help guide treatment and improve outcomes.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
This study tests whether regular brain scans (surveillance) help spot brain metastases early in people with HER2-positive breast cancer that has spread to other parts of the body. Participation involves being randomly assigned to either routine brain scans or no extra scans to see which approach is better.
This trial checks the brain using MRI in people with breast cancer that has spread outside the breast or can’t be fully removed. The goal is to screen for brain involvement and see how MRI findings fit with treatment timing, when it’s safe to do so.
This trial tests whether regular brain MRI scans can help detect brain metastases early in patients with stage IV breast cancer who do not yet have any known brain metastases. The goal is to see if early detection improves outcomes.
This trial checks whether taking screening brain MRI scans in people with stage IV breast cancer helps find brain involvement earlier. It may help guide treatment decisions for those who would otherwise only get brain imaging after symptoms start.
Hear when a new Brain Metastasases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.